Badgley, Phelps & Bell’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $12.5M | Buy |
319,156
+17,127
| +6% | +$666K | 0.46% | 77 |
|
|
2021
Q1 | $10.9M | Sell |
302,029
-14,086
| -4% | -$500K | 0.45% | 82 |
|
|
2020
Q4 | $11.6M | Sell |
316,115
-8,538
| -3% | -$313K | 0.5% | 75 |
|
|
2020
Q3 | $11.3M | Buy |
324,653
+7,528
| +2% | +$264K | 0.56% | 68 |
|
|
2020
Q2 | $9.84M | Sell |
317,125
-143,343
| -31% | -$4.87M | 0.54% | 71 |
|
|
2020
Q1 | $14.3M | Buy |
460,468
+15,283
| +3% | +$521K | 0.94% | 41 |
|
|
2019
Q4 | $16.5M | Buy |
445,185
+497
| +0.1% | +$17.7K | 0.87% | 44 |
|
|
2019
Q3 | $15.2M | Buy |
444,688
+12,025
| +3% | +$437K | 0.87% | 44 |
|
|
2019
Q2 | $17.8M | Sell |
432,663
-18
| -0% | -$715 | 1.04% | 30 |
|
|
2019
Q1 | $17.4M | Buy |
432,681
+15,061
| +4% | +$603K | 1.06% | 26 |
|
|
2018
Q4 | $17.3M | Buy |
417,620
+9,939
| +2% | +$413K | 1.25% | 17 |
|
|
2018
Q3 | $17M | Buy |
407,681
+11,873
| +3% | +$457K | 1.04% | 25 |
|
|
2018
Q2 | $13.6M | Buy |
395,808
+4,831
| +1% | +$165K | 0.88% | 36 |
|
|
2018
Q1 | $13.2M | Buy |
390,977
+15,657
| +4% | +$538K | 0.88% | 33 |
|
|
2017
Q4 | $12.9M | Buy |
375,320
+27,426
| +8% | +$935K | 0.89% | 31 |
|
|
2017
Q3 | $11.8M | Buy |
347,894
+3,538
| +1% | +$114K | 0.87% | 34 |
|
|
2017
Q2 | $11M | Buy |
344,356
+106,656
| +45% | +$3.36M | 0.86% | 38 |
|
|
2017
Q1 | $7.71M | Buy |
237,700
+265
| +0.1% | +$8.36K | 0.62% | 82 |
|
|
2016
Q4 | $7.32M | Buy |
237,435
+5,804
| +3% | +$177K | 0.63% | 77 |
|
|
2016
Q3 | $7.44M | Sell |
231,631
-1,263
| -0.5% | -$42.2K | 0.65% | 69 |
|
|
2016
Q2 | $7.78M | Sell |
232,894
-906
| -0.4% | -$28.9K | 0.71% | 60 |
|
|
2016
Q1 | $6.58M | Sell |
233,800
-90,771
| -28% | -$2.59M | 0.62% | 71 |
|
|
2015
Q4 | $9.94M | Buy |
324,571
+6,615
| +2% | +$208K | 0.98% | 35 |
|
|
2015
Q3 | $9.47M | Sell |
317,956
-2,488
| -0.8% | -$79.8K | 0.99% | 31 |
|
|
2015
Q2 | $10.2M | Sell |
320,444
-5,322
| -2% | -$173K | 1% | 35 |
|
|
2015
Q1 | $10.8M | Sell |
325,766
-5,905
| -2% | -$188K | 1.06% | 31 |
|
|
2014
Q4 | $9.8M | Sell |
331,671
-5,449
| -2% | -$156K | 0.96% | 40 |
|
|
2014
Q3 | $9.46M | Sell |
337,120
-1,241
| -0.4% | -$34.8K | 0.94% | 40 |
|
|
2014
Q2 | $9.53M | Sell |
338,361
-3,514
| -1% | -$100K | 0.95% | 37 |
|
|
2014
Q1 | $10.4M | Buy |
341,875
+2,207
| +0.6% | +$65.8K | 1.07% | 28 |
|
|
2013
Q4 | $9.87M | Buy |
339,668
+2,962
| +0.9% | +$86.2K | 1.04% | 29 |
|
|
2013
Q3 | $9.18M | Sell |
336,706
-2,563
| -0.8% | -$69.7K | 1.03% | 30 |
|
|
2013
Q2 | $9.02M | Buy |
+339,269
| New | +$9.37M | 1.06% | 25 |
|
Other funds holding PFE
Badgley, Phelps & Bell's PFE Position: Q2 2021 in Review
Badgley, Phelps & Bell increased its Pfizer (PFE) stake by 5.7% in Q2 2021, buying an estimated $666K and bringing the position to 319,156 shares worth $12.5M. The position accounts for 0.46% of the portfolio, ranked #77.
Badgley, Phelps & Bell first reported a position in PFE in Q2 2013 and has held it in 33 quarters since. The position peaked at $17.8M in Q2 2019. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- Badgley, Phelps & Bell held 319,156 shares of Pfizer worth $12.5M as of Q2 2021.
- Badgley, Phelps & Bell bought 17,127 Pfizer shares in Q2 2021, an estimated $666K.
- Pfizer made up 0.46% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #77 holding.
- Badgley, Phelps & Bell first reported a position in Pfizer in Q2 2013 and has held it in 33 quarters since.
- Badgley, Phelps & Bell's Pfizer position peaked at $17.8M in Q2 2019.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.